280 related articles for article (PubMed ID: 12899619)
1. Complex with a phage display-derived peptide provides insight into the function of insulin-like growth factor I.
Schaffer ML; Deshayes K; Nakamura G; Sidhu S; Skelton NJ
Biochemistry; 2003 Aug; 42(31):9324-34. PubMed ID: 12899619
[TBL] [Abstract][Full Text] [Related]
2. Molecular mimics of insulin-like growth factor 1 (IGF-1) for inhibiting IGF-1: IGF-binding protein interactions.
Lowman HB; Chen YM; Skelton NJ; Mortensen DL; Tomlinson EE; Sadick MD; Robinson IC; Clark RG
Biochemistry; 1998 Jun; 37(25):8870-8. PubMed ID: 9636028
[TBL] [Abstract][Full Text] [Related]
3. Total alanine-scanning mutagenesis of insulin-like growth factor I (IGF-I) identifies differential binding epitopes for IGFBP-1 and IGFBP-3.
Dubaquié Y; Lowman HB
Biochemistry; 1999 May; 38(20):6386-96. PubMed ID: 10350456
[TBL] [Abstract][Full Text] [Related]
4. Structure-function analysis of a phage display-derived peptide that binds to insulin-like growth factor binding protein 1.
Skelton NJ; Chen YM; Dubree N; Quan C; Jackson DY; Cochran A; Zobel K; Deshayes K; Baca M; Pisabarro MT; Lowman HB
Biochemistry; 2001 Jul; 40(29):8487-98. PubMed ID: 11456486
[TBL] [Abstract][Full Text] [Related]
5. Structural basis for the regulation of insulin-like growth factors by IGF binding proteins.
Siwanowicz I; Popowicz GM; Wisniewska M; Huber R; Kuenkele KP; Lang K; Engh RA; Holak TA
Structure; 2005 Jan; 13(1):155-67. PubMed ID: 15642270
[TBL] [Abstract][Full Text] [Related]
6. Structural changes in insulin-like growth factor (IGF) I mutant proteins affecting binding kinetic rates to IGF binding protein 1 and IGF-I receptor.
Jansson M; Uhlen M; Nilsson B
Biochemistry; 1997 Apr; 36(14):4108-17. PubMed ID: 9100004
[TBL] [Abstract][Full Text] [Related]
7. The N-terminal subdomain of insulin-like growth factor (IGF) binding protein 6. Structure and interaction with IGFs.
Chandrashekaran IR; Yao S; Wang CC; Bansal PS; Alewood PF; Forbes BE; Wallace JC; Bach LA; Norton RS
Biochemistry; 2007 Mar; 46(11):3065-74. PubMed ID: 17305365
[TBL] [Abstract][Full Text] [Related]
8. Diversity of human insulin-like growth factor (IGF) binding protein-2 fragments in plasma: primary structure, IGF-binding properties, and disulfide bonding pattern.
Mark S; Kübler B; Höning S; Oesterreicher S; John H; Braulke T; Forssmann WG; Ständker L
Biochemistry; 2005 Mar; 44(9):3644-52. PubMed ID: 15736974
[TBL] [Abstract][Full Text] [Related]
9. Solution structure of a phage-derived peptide antagonist in complex with vascular endothelial growth factor.
Pan B; Li B; Russell SJ; Tom JY; Cochran AG; Fairbrother WJ
J Mol Biol; 2002 Feb; 316(3):769-87. PubMed ID: 11866530
[TBL] [Abstract][Full Text] [Related]
10. Interaction of insulin-like growth factor (IGF)-I and -II with IGF binding protein-2: mapping the binding surfaces by nuclear magnetic resonance.
Carrick FE; Hinds MG; McNeil KA; Wallace JC; Forbes BE; Norton RS
J Mol Endocrinol; 2005 Jun; 34(3):685-98. PubMed ID: 15956340
[TBL] [Abstract][Full Text] [Related]
11. How insulin binds: the B-chain alpha-helix contacts the L1 beta-helix of the insulin receptor.
Huang K; Xu B; Hu SQ; Chu YC; Hua QX; Qu Y; Li B; Wang S; Wang RY; Nakagawa SH; Theede AM; Whittaker J; De Meyts P; Katsoyannis PG; Weiss MA
J Mol Biol; 2004 Aug; 341(2):529-50. PubMed ID: 15276842
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and characterization of biotinylated forms of insulin-like growth factor-1: topographical evaluation of the IGF-1/IGFBP-2 AND IGFBP-3 interface.
Robinson SA; Rosenzweig SA
Biochemistry; 2004 Sep; 43(36):11533-45. PubMed ID: 15350139
[TBL] [Abstract][Full Text] [Related]
13. Crystal structure of the first three domains of the type-1 insulin-like growth factor receptor.
Garrett TP; McKern NM; Lou M; Frenkel MJ; Bentley JD; Lovrecz GO; Elleman TC; Cosgrove LJ; Ward CW
Nature; 1998 Jul; 394(6691):395-9. PubMed ID: 9690478
[TBL] [Abstract][Full Text] [Related]
14. C-terminal domain of insulin-like growth factor (IGF) binding protein 6: conformational exchange and its correlation with IGF-II binding.
Yao S; Headey SJ; Keizer DW; Bach LA; Norton RS
Biochemistry; 2004 Sep; 43(35):11187-95. PubMed ID: 15366928
[TBL] [Abstract][Full Text] [Related]
15. Molecular recognition characteristics in the insulin-like growth factor (IGF)-insulin-like growth factor binding protein -3/5 (IGFBP-3/5) heparin axis.
Beattie J; Phillips K; Shand JH; Szymanowska M; Flint DJ; Allan GJ
J Mol Endocrinol; 2005 Feb; 34(1):163-75. PubMed ID: 15691886
[TBL] [Abstract][Full Text] [Related]
16. Structure and binding determinants of the recombinant kringle-2 domain of human plasminogen to an internal peptide from a group A Streptococcal surface protein.
Rios-Steiner JL; Schenone M; Mochalkin I; Tulinsky A; Castellino FJ
J Mol Biol; 2001 May; 308(4):705-19. PubMed ID: 11350170
[TBL] [Abstract][Full Text] [Related]
17. Insulin-like growth factor binding proteins-3 and -5 form sodium dodecyl sulfate-stable multimers.
Koedam JA; Hoogerbrugge CM; Van Buul-Offers SC
Biochem Biophys Res Commun; 1997 Nov; 240(3):707-14. PubMed ID: 9398631
[TBL] [Abstract][Full Text] [Related]
18. Contributions of the N- and C-terminal domains of IGF binding protein-6 to IGF binding.
Headey SJ; Leeding KS; Norton RS; Bach LA
J Mol Endocrinol; 2004 Oct; 33(2):377-86. PubMed ID: 15525596
[TBL] [Abstract][Full Text] [Related]
19. Structures of phage-display peptides that bind to the malarial surface protein, apical membrane antigen 1, and block erythrocyte invasion.
Keizer DW; Miles LA; Li F; Nair M; Anders RF; Coley AM; Foley M; Norton RS
Biochemistry; 2003 Aug; 42(33):9915-23. PubMed ID: 12924940
[TBL] [Abstract][Full Text] [Related]
20. Cooperativity of the N- and C-terminal domains of insulin-like growth factor (IGF) binding protein 2 in IGF binding.
Kuang Z; Yao S; McNeil KA; Thompson JA; Bach LA; Forbes BE; Wallace JC; Norton RS
Biochemistry; 2007 Dec; 46(48):13720-32. PubMed ID: 17985932
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]